Literature DB >> 30043291

[Limits of surgery in uro-oncology].

A Heidenreich1,2.   

Abstract

The limits of cancer surgery in uro-oncology are characterized by a carefully weighed risk of surgical feasibility and oncological necessity. The limits of uro-oncological cancer surgery do not represent fixed dogmas but ideally these more or less cognitive boundaries move based on new scientific findings, improved imaging modalities, optimized surgical techniques and perioperative care. The limits of cancer surgery are defined by patient-specific parameters, the biological aggressiveness of the tumor itself, the skills and expertise of the surgeon, and adequate perioperative care of the patient. Dependent on the origin of the cancers of the upper and lower urogenital tract, the specific particularities of each individual cancer in terms of prognosis need to be known, taking into consideration the newest molecular insights and modern multimodality treatment regimes. Only the consideration of the above mentioned basics will allow the best decision to be made with the patient concerning the optimal individual treatment. The current article highlights general parameters of the patient, tumor and surgeon which might define the limits of cancer surgery in uro-oncology. In addition, specific clinical scenarios are discussed with regard to surgery limits in cancer of the kidney, the prostate and the testis.

Entities:  

Keywords:  Germ cell tumor; Prostate cancer; Radical prostatectomy; Renal cell carcinoma; Testis cancer

Mesh:

Year:  2018        PMID: 30043291     DOI: 10.1007/s00120-018-0735-y

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  53 in total

1.  Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes.

Authors:  Andrew G McIntosh; Benjamin T Ristau; Karen Ruth; Rachel Jennings; Eric Ross; Marc C Smaldone; David Y T Chen; Rosalia Viterbo; Richard E Greenberg; Alexander Kutikov; Robert G Uzzo
Journal:  Eur Urol       Date:  2018-04-04       Impact factor: 20.096

2.  Percutaneous biopsy of the renal mass: FNA or core needle biopsy?

Authors:  Chi-Shun Yang; Euna Choi; Muhammad T Idrees; Shaoxiong Chen; Howard H Wu
Journal:  Cancer Cytopathol       Date:  2017-03-23       Impact factor: 5.284

3.  Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.

Authors:  Georgios Gakis; Tilman Todenhöfer; Markus Renninger; David Schilling; Karl-Dietrich Sievert; Christian Schwentner; Arnulf Stenzl
Journal:  BJU Int       Date:  2011-04-20       Impact factor: 5.588

Review 4.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

5.  Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Authors:  Daniel Y C Heng; J Connor Wells; Brian I Rini; Benoit Beuselinck; Jae-Lyun Lee; Jennifer J Knox; Georg A Bjarnason; Sumanta Kumar Pal; Christian K Kollmannsberger; Takeshi Yuasa; Sandy Srinivas; Frede Donskov; Aristotelis Bamias; Lori A Wood; D Scott Ernst; Neeraj Agarwal; Ulka N Vaishampayan; Sun Young Rha; Jenny J Kim; Toni K Choueiri
Journal:  Eur Urol       Date:  2014-06-13       Impact factor: 20.096

Review 6.  [Multimodal therapy of locally advanced prostate cancer].

Authors:  A Heidenreich; D Böhmer
Journal:  Urologe A       Date:  2016-03       Impact factor: 0.639

7.  Psychosocial and physical outcomes of in- and outpatient rehabilitation in prostate cancer patients treated with radical prostatectomy.

Authors:  Hilke M Rath; Anneke Ullrich; Ullrich Otto; Christa Kerschgens; Martin Raida; Christa Hagen-Aukamp; Uwe Koch; Corinna Bergelt
Journal:  Support Care Cancer       Date:  2016-01-23       Impact factor: 3.603

8.  Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors.

Authors:  Umberto Capitanio; Claudio Jeldres; Paul Perrotte; Hendrik Isbarn; Maxime Crépel; Vincent Cloutier; Sara Baillargeon-Gagne; Shahrokh F Shariat; Alain Duclos; Philippe Arjane; Hugues Widmer; Fred Saad; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Urology       Date:  2009-06-07       Impact factor: 2.649

Review 9.  Preoperative imaging in renal cell cancer.

Authors:  Axel Heidenreich; Vincent Ravery
Journal:  World J Urol       Date:  2004-07-30       Impact factor: 4.226

Review 10.  Active surveillance review: contemporary selection criteria, follow-up, compliance and outcomes.

Authors:  Maria Komisarenko; Lisa J Martin; Antonio Finelli
Journal:  Transl Androl Urol       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.